Welcome to licensed pharmacies in Poland:
Non-prescription medicines delivery across Europe.
Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.
Can Rinvoq cause melanoma?
Good morning I wanted to know if, as it is written on the leaflet, the risk of melanoma is one in 10 people.
Thank you
* required field
* required field
Other messages will not be sent.
Suggested Products
Space for your product
Katarzyna Kosińska Pharmacist, Editor
38 days ago
Important information about the risk of cancer with Rinvoq:
"Patients with rheumatoid arthritis have an increased risk of malignant tumors, including lymphomas. Immunomodulatory medicinal products may increase the risk of malignancies, including lymphomas. Currently available clinical data are limited and long-term studies are being conducted.
In clinical trials with upadacitinib (Rinvoq), malignancies have been observed. The risks and benefits of Rinvoq treatment should be weighed before initiating treatment in patients with known malignancies.
Non-melanoma skin carcinomas have been reported in patients treated with upadacitinib. Periodic skin examinations are recommended in patients at increased risk of skin cancer."
In conclusion, the summary of product characteristics indicates an increased risk of non-melanoma skin cancer and lymphoma. No risk of melanoma development was identified. The most common side effects are upper respiratory tract infections and acne.
I encourage you to read: